… No such predictive biomarkers for bevacizumab have been … VEGFA levels may
correlate with clinical outcomes. Our … while receiving first-line therapy with a bevacizumab-containing …

… approval for bevacizumab as first-line treatment for MBC. … positive correlation between
treatment-induced hypertension … colorectal cancer patients treated with first-line bevacizumab. …

… correlation to metastatic potential and disease extension of … , their serial assessment
and clinical correlations were pre-… monitoring of mCRC patients during first-line BEV-containing …

… Bevacizumab is currently being investigated in patients with metastatic colorectal cancer who
failed first-line therapy, … In addition, the overexpression of VEGF often correlates with a poor …

… model that adjusted for the correlation of patient PFS assessments within a site … patients
with metastatic colorectal cancer who received bevacizumab plus chemotherapy in the first-line …

… patients (six renal cancer patients and 16 colorectal cancer patients) who were being treated
with bevacizumab … was no correlation between the development of hypertension and serum …

… the first cycle of treatment correlated with clinical outcome [38]. … 53 ovarian cancer patients
treated with bevacizumab and low … As reported above, CRC patients treated with bevacizumab …

… of first-line chemotherapy plus bevacizumab (2.5 mg/kg/week every 2 or 3 weeks) in the
context of general practice in the Oncology Department of our Medical … The correlation between …

… Nearly 75% of all colorectal cancer patients are aged ≥65 … MCRC patients who were treated
with first-line bevacizumab and … mRNA in tumor cells directly correlated with the growth of …

… collections, and 10 retrospective case series were included in this analysis for a total of
3502 patients treated with FOLFIRI-B chemotherapy as first-line treatment. The number of …